Vorasidenib – March 2026

Tablet 10 mg, Tablet 40 mg

  • Brand names:
    • Voranigo®
  • Pharmaceutical Company:
    • SERVIER LABORATORIES (AUST.) PTY. LTD.
  • Condition/Indication: Astrocytoma or oligodendroglioma
  • Meeting Date: March 2026
Public Summary Documents
Last updated
11 March 2026